Analysts Offer Predictions for Core Scientific Q1 Earnings

Core Scientific, Inc. (NASDAQ:CORZ) – Investment analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Core Scientific in a report issued on Tuesday, March 3rd. HC Wainwright analyst K. Dede forecasts that the company will earn $0.07 per share for the quarter. HC Wainwright has a “Buy” rating and a $25.00 price objective on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. HC Wainwright also issued estimates for Core Scientific’s Q2 2026 earnings at $0.09 EPS, Q3 2026 earnings at $0.09 EPS, Q4 2026 earnings at $0.09 EPS and FY2026 earnings at $0.33 EPS.

A number of other research analysts also recently weighed in on CORZ. Canaccord Genuity Group increased their price target on Core Scientific from $17.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. Citizens Jmp upgraded Core Scientific from a “market perform” rating to an “outperform” rating and set a $30.00 target price on the stock in a report on Thursday, December 18th. Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 13th. Finally, Cantor Fitzgerald lowered their price target on Core Scientific from $26.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $24.84.

Core Scientific Stock Performance

Shares of CORZ stock opened at $16.00 on Thursday. The firm’s 50 day moving average price is $17.28 and its two-hundred day moving average price is $16.95. Core Scientific has a 52-week low of $6.20 and a 52-week high of $23.63. The stock has a market cap of $5.05 billion, a PE ratio of 13.68 and a beta of 6.87.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Monday, March 2nd. The company reported $0.42 EPS for the quarter, topping the consensus estimate of ($0.27) by $0.69. The business had revenue of $79.76 million for the quarter, compared to analyst estimates of $118.45 million. The firm’s quarterly revenue was down 16.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.69) EPS.

Hedge Funds Weigh In On Core Scientific

Large investors have recently added to or reduced their stakes in the company. Allworth Financial LP raised its position in shares of Core Scientific by 206.5% in the third quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock valued at $25,000 after purchasing an additional 950 shares during the period. Larson Financial Group LLC boosted its holdings in Core Scientific by 936.7% in the 4th quarter. Larson Financial Group LLC now owns 1,866 shares of the company’s stock worth $27,000 after buying an additional 1,686 shares during the period. HHM Wealth Advisors LLC grew its stake in Core Scientific by 96.5% in the 2nd quarter. HHM Wealth Advisors LLC now owns 1,926 shares of the company’s stock valued at $33,000 after buying an additional 946 shares in the last quarter. Osaic Holdings Inc. grew its stake in Core Scientific by 112.1% in the 2nd quarter. Osaic Holdings Inc. now owns 2,017 shares of the company’s stock valued at $34,000 after buying an additional 1,066 shares in the last quarter. Finally, Danske Bank A S bought a new stake in Core Scientific during the 4th quarter valued at $36,000.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: HC Wainwright reiterated a Buy, materially raised FY2026 EPS (from $0.16 to $0.33) and published quarterly EPS estimates with a $25 price target — a clear analyst endorsement that supports the rally. HC Wainwright Reiterates Buy
• Positive Sentiment: Canaccord raised its price target from $17 to $20 and maintained a Buy rating, adding upward price-target momentum. Canaccord PT Raised to $20
• Positive Sentiment: MarketBeat and other coverage argue the company’s pivot to AI colocation (including a reported $10B+ backlog and rapid colocation growth) creates multi-year upside and institutional buying support, which can drive investor interest despite short-term churn. Core Scientific’s $10 Billion AI Shift
• Neutral Sentiment: CoreWeave contract progress: reports note the CoreWeave deal is ahead of schedule and colocation revenue is ramping, a structural positive; however, this is balanced by transitional revenue mix changes. CoreWeave Deal Ahead of Schedule
• Neutral Sentiment: Short-interest data in recent filings shows anomalous “0 shares” readings (likely a reporting glitch); current days-to-cover appears negligible — this item is noisy and should not be overinterpreted.
• Negative Sentiment: Q4 2025 results showed revenue weakness (reported as a 38% YoY decline in one summary) and a sharp earnings swing tied to the pivot, which earlier drove a significant intraday drop. Investors remain sensitive to near-term top-line contraction and negative adjusted EBITDA while expansion investments continue. Core Scientific 2025 earnings: revenue falls 38% YoY
• Negative Sentiment: At least one firm (Ladenburg Thalmann) lowered expectations, reflecting some analyst caution on near-term execution risks and balance-sheet concerns tied to the transition. Ladenburg Lowers Expectations

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.